Related Experiment Videos
Biliary atresia--a 25-year survey
R Engelskirchen1, A M Holschneider, M Gharib
1Kinderchirurgische Klinik des Kinderkrankenhauses der Stadt Köln.
Insights
Biliary atresia treatment in 90 children showed a 30% survival rate. Surgical interventions like Kasai-Kimura hepatoporto-jejunostomy offered limited long-term biliary flow, with only one child fully recovering.
Area of Science:
- Pediatric Surgery
- Hepatology
- Gastroenterology
Background:
- Biliary atresia is a severe neonatal liver disease requiring surgical intervention.
- Treatment outcomes for biliary atresia have historically varied.
- Long-term results of surgical procedures for biliary atresia need continuous evaluation.
Purpose of the Study:
- To evaluate the long-term prognosis and outcomes of surgical treatments for biliary atresia in pediatric patients.
- To assess the effectiveness of different surgical techniques, including Kasai-Kimura hepatoporto-jejunostomy.
- To analyze survival rates and postoperative biliary flow in children treated for biliary atresia.
Main Methods:
- Retrospective analysis of 90 children treated for biliary atresia between 1963 and 1988.
- Categorization of patients based on lesion type (intrahepatic, extrahepatic, or both).
- Review of surgical interventions including drainage operations, diagnostic laparotomy, hepato-jejunostomy, cholecystoduodenostomy, and Kasai-Kimura hepatoporto-jejunostomy.
Main Results:
- Overall survival rate was 30% (27 out of 90 patients).
- Patients with intrahepatic bile duct hypoplasia had a higher survival rate (80%).
- Hepatoporto-jejunostomy resulted in lasting postoperative biliary flow in only 5 of 29 cases, with one child achieving full recovery.
Conclusions:
- Surgical interventions for biliary atresia, including Kasai-Kimura hepatoporto-jejunostomy, demonstrate limited long-term success in achieving sustained biliary flow and complete recovery.
- Intrahepatic bile duct hypoplasia appears to be a significant prognostic factor for improved survival.
- Further research is needed to improve surgical outcomes and long-term management of biliary atresia.
Abstract:
In the past 25 years, from 1963 to 1988, 90 children from the Department of Pediatric Surgery of the Pediatric Hospital in Cologne, Germany were treated for biliary atresia. Of these, 47 had purely extrahepatic bile duct lesions, 21 had purely intrahepatic bile duct lesions, and 22 had both extrahepatic and intrahepatic bile duct lesions. Forty-five of the children underwent a drainage operation, whereas the remaining 45 children underwent no surgery at all or simply a diagnostic laparotomy. Until 1966 hepato-jejunostomy with implantation of artificial bile ducts was conducted in 12 cases. Later, cholecystoduodenostomy was performed 4 times and hepatoporto-jejunostomy according to Kasai-Kimura 29 times. The latter was performed either without and enterostomy (n = 16) or with an enterostomy in the respective intestinal loop (n = 13). 27 patients survived (30%). If only the children with intrahepatic bile duct hypoplasia are considered, the survival rate was 12 out of 15 patients (80%). Eight children (27.5%) of the 29 with hepatoporto-jejunostomy are still alive today. This survival rate, compared with the survival rate of the total, is comparably large with 27.7%. Current data from the 23 surviving patients was retrospectively gathered in our hospital or was collected from outside the establishment. It was analyzed with regard to prognosis and long-term results. Only in 5 of the 29 cases of children with hepatoporto-jejunostomy could a lasting postoperative biliary flow be achieved. Only one of the children can be classified as completely healthy in regard to his liver.(ABSTRACT TRUNCATED AT 250 WORDS)